| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Axonal transport and neurodegenerative disease: Can we see the elephant?
|
Goldstein, Lawrence S.B.
|
|
2012
|
99 |
3 |
p. 186-190
5 p.
|
article
|
| 2 |
Charcot–Marie–Tooth disease and intracellular traffic
|
Bucci, Cecilia
|
|
2012
|
99 |
3 |
p. 191-225
35 p.
|
article
|
| 3 |
Developing treatment for spinal and bulbar muscular atrophy
|
Fischbeck, Kenneth H.
|
|
2012
|
99 |
3 |
p. 257-261
5 p.
|
article
|
| 4 |
Editorial Board
|
|
|
2012
|
99 |
3 |
p. CO2-
1 p.
|
article
|
| 5 |
Good gene, bad gene: New APP variant may be both
|
Di Fede, Giuseppe
|
|
2012
|
99 |
3 |
p. 281-292
12 p.
|
article
|
| 6 |
Neurodegeneration as an RNA disorder
|
Johnson, Rory
|
|
2012
|
99 |
3 |
p. 293-315
23 p.
|
article
|
| 7 |
Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA)
|
Katsuno, Masahisa
|
|
2012
|
99 |
3 |
p. 246-256
11 p.
|
article
|
| 8 |
SCA1—Phosphorylation, a regulator of Ataxin-1 function and pathogenesis
|
Orr, Harry T.
|
|
2012
|
99 |
3 |
p. 179-185
7 p.
|
article
|
| 9 |
Structural features and cytotoxicity of amyloid oligomers: Implications in Alzheimer's disease and other diseases with amyloid deposits
|
Stefani, Massimo
|
|
2012
|
99 |
3 |
p. 226-245
20 p.
|
article
|
| 10 |
Therapeutic approaches to preventing cell death in Huntington disease
|
Kaplan, Anna
|
|
2012
|
99 |
3 |
p. 262-280
19 p.
|
article
|
Journal description